# Commission Regulation (EC) No 581/2009 of 3 July 2009 amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards gamithromycin (Text with EEA relevance), Annex

Extent: E+W+S+N.I.

In point 1.2.4 of Annex I (List of pharmacologically active substances for which maximum residue limits have been fixed) to Regulation (EEC) No 2377/90 the following entry for ‘Gamithromycin’ is inserted after erythromycin:
Pharmacologically active substance(s)
Marker residue
Animal species
MRLs
Target tissues
Other provisions
‘Gamithromycin
Gamithromycin
Bovine
20 μg/kg
Fat
Not for use in animals producing milk for human consumption.’
200 μg/kg
Liver
100 μg/kg
Kidney

---
Source: https://www.legislation.gov.uk/eur/2009/581/annex (the official version)
Page: https://openlegislation.uk/eu-regulation-2009-581/annex
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.